SCHEMBL28482437

SCHEMBL28482437

CN1CCCN(S(=O)(=O)c2[c]c(C(F)(F)F)cc([N+](=O)[O-])c2)CC1

nearest known ligand 0.47

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.43
CYP2C19 P33261 2/20 0.43
HTT P42858 2/20 0.43
CYP1A2 P05177 1/20 0.43
CYP3A4 P08684 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
RAB9A P51151 1/20 0.41
KMT2A Q03164 1/20 0.41
PKM P14618 2/20 0.40
VCAM1 P19320 1/20 0.40
APOBEC3A P31941 1/20 0.39
APOBEC3G Q9HC16 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
LMNA P02545 2/20 0.38
POLB P06746 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28478897 0.98 ALDH1A1 (0.40) ALDH1A1CYP2C19HTTCYP1A2CYP3A4
SCHEMBL28482466 0.95 SMN1; SMN2 (0.44) ALDH1A1CYP2C19HTTCYP1A2CYP3A4
SCHEMBL28480715 0.84 KMT2A (0.47) ALDH1A1CYP2C19HTTCYP1A2CYP3A4
SCHEMBL28473212 0.84 ALDH1A1 (0.46) ALDH1A1CYP2C19HTTCYP1A2CYP3A4
SCHEMBL29202922 0.83 MAPT (0.52) ALDH1A1HTTKMT2ALMNAPOLB
SCHEMBL28477490 0.81 SMN1; SMN2 (0.37) ALDH1A1SMN1; SMN2KMT2APKML3MBTL1
SCHEMBL28486029 0.81 L3MBTL1 (0.43) ALDH1A1CYP2C19HTTCYP1A2CYP3A4
SCHEMBL28901016 0.81 L3MBTL1 (0.46) ALDH1A1CYP2C19HTTCYP1A2CYP3A4
SCHEMBL29202905 0.80 TRPV4 (0.40) ALDH1A1HTTSMN1; SMN2KMT2AL3MBTL1
SCHEMBL28485486 0.78 HTT (0.47) ALDH1A1CYP2C19HTTCYP1A2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111918864-A Prodrug compounds activated by AKR1C3 and their use to treat hyperproliferative disorders 阿基利斯医疗有限公司 2020-11-10 CN disclosed